Baillou, 2003, Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy, Aids, 17, 563, 10.1097/00002030-200303070-00012
Berkowitz, 1998, CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation, J. Immunol., 161, 3702, 10.4049/jimmunol.161.7.3702
Bonyhadi, 1993, HIV induces thymus depletion in vivo, Nature, 363, 728, 10.1038/363728a0
Brady, 1993, CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration, EMBO J., 12, 4923, 10.1002/j.1460-2075.1993.tb06186.x
Deacon, 1995, Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients, Science, 270, 988, 10.1126/science.270.5238.988
Deichmann, 1997, Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells, Blood, 89, 3522, 10.1182/blood.V89.10.3522
Dion, 2004, HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation, Immunity, 21, 757, 10.1016/j.immuni.2004.10.013
Douek, 2001, Evidence for increased T cell turnover and decreased thymic output in HIV infection, J. immunol., 167, 6663, 10.4049/jimmunol.167.11.6663
Duus, 2001, Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus, J. Virol., 75, 3916, 10.1128/JVI.75.8.3916-3924.2001
Fackler, 2002, Live and let die: Nef functions beyond HIV replication, Immunity, 16, 493, 10.1016/S1074-7613(02)00307-2
Garcia, 1991, Serine phosphorylation-independent downregulation of cell-surface CD4 by nef, Nature, 350, 508, 10.1038/350508a0
Geleziunas, 2001, HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell, Nature, 410, 834, 10.1038/35071111
Guatelli, 1990, Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells, J. Virol., 64, 4093, 10.1128/JVI.64.9.4093-4098.1990
Hanna, 1998, Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease, J. Virol., 72, 121, 10.1128/JVI.72.1.121-132.1998
Hanna, 2001, The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck, J. Virol., 75, 9378, 10.1128/JVI.75.19.9378-9392.2001
Hatzakis, 2000, Effect of recent thymic emigrants on progression of HIV-1 disease, Lancet, 355, 599, 10.1016/S0140-6736(99)10311-8
Itano, 1994, A role for the cytoplasmic tail of the beta chain of CD8 in thymic selection, Immunity, 1, 287, 10.1016/1074-7613(94)90080-9
Jamieson, 1994, Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity, J. Virol., 68, 3478, 10.1128/JVI.68.6.3478-3485.1994
Janardhan, 2004, HIV-1 Nef binds the DOCK2–ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis, PLoS Biol., 2, E6, 10.1371/journal.pbio.0020006
Kestler, 1991, Importance of the nef gene for maintenance of high virus loads and for development of AIDS, Cell, 65, 651, 10.1016/0092-8674(91)90097-I
Knutsen, 1999, Inhibition of thymopoiesis of CD34+ cell maturation by HIV-1 in an in vitro CD34+ cell and thymic epithelial organ culture model, Stem Cells, 17, 327, 10.1002/stem.170327
La Motte-Mohs, 2005, Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro, Blood, 105, 1431, 10.1182/blood-2004-04-1293
Lefort, 2006, Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cells, Exp. Hematol., 34, 1720, 10.1016/j.exphem.2006.08.007
Levy, 2006, [Cytokine therapies in HIV infection], Med. Sci. (Paris), 22, 751
Michel, 2005, The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4, Curr Biol, 15, 714, 10.1016/j.cub.2005.02.058
Moanna, 2005, CD4+ T-cell depletion in HIV infection: killed by friendly fire?, Curr. HIV/AIDS Rep., 2, 16, 10.1007/s11904-996-0004-3
Neal, 1995, CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1, Blood, 86, 1749, 10.1182/blood.V86.5.1749.bloodjournal8651749
Rahemtulla, 1991, Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4, Nature, 353, 180, 10.1038/353180a0
Reynaud, 2003, In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells, Blood, 101, 4313, 10.1182/blood-2002-07-2085
Richardson, 2000, Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection, Biomed. Pharmacother., 54, 21, 10.1016/S0753-3322(00)88637-0
Robert-Guroff, 1990, Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages, J. Virol., 64, 3391, 10.1128/JVI.64.7.3391-3398.1990
Ruiz, 1998, Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV, J. Immunol., 161, 4169, 10.4049/jimmunol.161.8.4169
Schmitt, 2002, Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro, Immunity, 17, 749, 10.1016/S1074-7613(02)00474-0
Schnittman, 1990, Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion, Proc. Natl. Acad. Sci. U. S. A., 87, 7727, 10.1073/pnas.87.19.7727
Schrager, 1999, HIV-1 Nef increases T cell activation in a stimulus-dependent manner, Proc. Natl. Acad. Sci. U. S. A., 96, 8167, 10.1073/pnas.96.14.8167
Schwartz, 1996, Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein, Nat. Med., 2, 338, 10.1038/nm0396-338
Simmons, 2001, Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators, Immunity, 14, 763, 10.1016/S1074-7613(01)00158-3
Sirven, 2001, Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors, Mol. Ther., 3, 438, 10.1006/mthe.2001.0282
Skowronski, 1993, Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene, EMBO J., 12, 703, 10.1002/j.1460-2075.1993.tb05704.x
Sol-Foulon, 2002, HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread, Immunity, 16, 145, 10.1016/S1074-7613(02)00260-1
Sol-Foulon, 2004, The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts, J. Biol. Chem., 279, 31398, 10.1074/jbc.M401621200
Stanley, 1992, CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals, J. Immunol., 149, 689, 10.4049/jimmunol.149.2.689
Stoddart, 2003, Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis, J. Virol., 77, 2124, 10.1128/JVI.77.3.2124-2133.2003
Stove, 2003, Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development, Blood, 102, 2925, 10.1182/blood-2003-03-0833
Stove, 2005, Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta, J. Virol., 79, 11422, 10.1128/JVI.79.17.11422-11433.2005
Stumptner-Cuvelette, 2001, HIV-1 Nef impairs MHC class II antigen presentation and surface expression, Proc. Natl. Acad. Sci. U. S. A., 98, 12144, 10.1073/pnas.221256498
Su, 1995, HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo, Immunity, 2, 25, 10.1016/1074-7613(95)90076-4
Swigut, 2001, Mechanism for down-regulation of CD28 by Nef, EMBO J., 20, 1593, 10.1093/emboj/20.7.1593
Tolstrup, 2004, HIV/SIV escape from immune surveillance: focus on Nef, Curr. HIV Res., 2, 141, 10.2174/1570162043484924
Valentin, 1994, Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro, J. Virol., 68, 3041, 10.1128/JVI.68.5.3041-3050.1994
Verhasselt, 1999, Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells, Blood, 94, 2809, 10.1182/blood.V94.8.2809.420k11_2809_2818
von Laer, 1990, CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus, Blood, 76, 1281, 10.1182/blood.V76.7.1281.1281
Weichold, 1998, Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures, Blood, 91, 907, 10.1182/blood.V91.3.907
Xu, 1999, Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain, J. Exp. Med., 189, 1489, 10.1084/jem.189.9.1489
Zaitseva, 1998, CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection, J. Immunol., 161, 3103, 10.4049/jimmunol.161.6.3103
Zauli, 1994, In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line, Blood, 83, 167, 10.1182/blood.V83.1.167.167
Zauli, 1999, Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway, Blood, 93, 1000, 10.1182/blood.V93.3.1000